-+ 0.00%
-+ 0.00%
-+ 0.00%

Boston Scientific forecasts Q4 2026 net sales decline of 1%-3%

PUBT·10/28/2026 10:40:07
Boston Scientific forecasts Q4 2026 net sales decline of 1%-3%
  • Boston Scientific forecasts full-year 2026 adjusted earnings of $3.16-$3.18 per share.
  • Annual reported sales growth is projected at approximately 4.25%; organic growth is expected at approximately 3.75%.
  • Fourth-quarter 2026 reported sales are expected to decline 1%-3% year over year, matching the organic sales outlook.
  • Adjusted earnings are forecast at $0.77-$0.79 per share for the quarter.
  • Third-quarter 2026 sales rose 1.5% to $5.14 billion, with several businesses affected by a cyber incident.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boston Scientific Corporation published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.